BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 12709917)

  • 1. Prediction, prevention, and treatment of venous thromboembolic disease in pregnancy.
    Zotz RB; Gerhardt A; Scharf RE
    Semin Thromb Hemost; 2003 Apr; 29(2):143-54. PubMed ID: 12709917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pregnancy-associated venous thromboembolic disease: prediction, prevention, and therapy].
    Zotz RB; Gerhardt A; Scharf RE
    Hamostaseologie; 2006 Jan; 26(1):63-71. PubMed ID: 16444326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited thrombophilia and gestational venous thromboembolism.
    Zotz RB; Gerhardt A; Scharf RE
    Best Pract Res Clin Haematol; 2003 Jun; 16(2):243-59. PubMed ID: 12763490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited thrombophilia and gestational venous thromboembolism.
    Conard J; Horellou MH; Samama MM
    Semin Thromb Hemost; 2003 Apr; 29(2):131-42. PubMed ID: 12709916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pregnancy-associated venous thrombosis in women with hereditary heterozygous factor V Leiden and/or factor II gene mutations].
    Samama MM; Rached RA; Conard J; Horellou MH; Elalamy I
    Bull Acad Natl Med; 2004; 188(8):1377-93; discussion 1393-6. PubMed ID: 15918665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombophilic conditions in the pathogenesis of venous thromboembolism].
    Poul H
    Vnitr Lek; 2006 Mar; 52 Suppl 1():17-25. PubMed ID: 16637445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of dalteparin (Fragmin) on thrombin generation in pregnant women with venous thromboembolism: significance of the factor V Leiden mutation.
    Schambeck CM; Eberl E; Geisen U; Grossmann R; Keller F
    Thromb Haemost; 2001 May; 85(5):782-6. PubMed ID: 11372668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism during pregnancy.
    Dresang LT; Fontaine P; Leeman L; King VJ
    Am Fam Physician; 2008 Jun; 77(12):1709-16. PubMed ID: 18619081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and management of venous thromboembolism in pregnancy.
    James AH
    Am J Med; 2007 Oct; 120(10 Suppl 2):S26-34. PubMed ID: 17916457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.
    Brill-Edwards P; Ginsberg JS; Gent M; Hirsh J; Burrows R; Kearon C; Geerts W; Kovacs M; Weitz JI; Robinson KS; Whittom R; Couture G;
    N Engl J Med; 2000 Nov; 343(20):1439-44. PubMed ID: 11078768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilias and recurrent pregnancy loss.
    Kutteh WH; Triplett DA
    Semin Reprod Med; 2006 Feb; 24(1):54-66. PubMed ID: 16418978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.
    Johnston JA; Brill-Edwards P; Ginsberg JS; Pauker SG; Eckman MH
    Am J Med; 2005 May; 118(5):503-14. PubMed ID: 15866253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombophilia and the prevention of thromboembolic complications during pregnancy and the puerperium].
    Wouters MG; Nováková IR; Steegers EA
    Ned Tijdschr Geneeskd; 2003 May; 147(22):1060-6. PubMed ID: 12814017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Travel, venous thromboembolism, and thrombophilia.
    Gallus AS
    Semin Thromb Hemost; 2005 Feb; 31(1):90-6. PubMed ID: 15706480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who should be tested for thrombophilia?
    Simioni P
    Curr Opin Hematol; 2006 Sep; 13(5):337-43. PubMed ID: 16888438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombophilic states: their relevance in prevention and treatment of venous thromboembolism].
    Poul H; Kessler P
    Vnitr Lek; 2009 Mar; 55(3):242-52. PubMed ID: 19378855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations.
    Couto E; Nomura ML; Barini R; Pinto e Silva JL
    Sao Paulo Med J; 2005 Nov; 123(6):286-8. PubMed ID: 16444389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.